| KwFwLL-NH2 | IC50 | 61.0 [1] |
| KwFwLL-NH2 | Ki | 255.0 [1] |
| Ibutamoren | IC50 | 0.4 [1] |
| Ibutamoren | Ki | 0.24 [1] |
| CID 44576256 | IC50 | 0.14 [1] |
| CID 44576256 | Ki | 0.7 [1] |
| 6-Ethyl-5-[4-[(4-methylsulfonylphenyl)methylamino]phenyl]pyrimidine-2,4-diamine | IC50 | 7.0 [1], 9.7 [2], 12.0 [3], 37.0 [4] |
| 3-(2,6-Dichlorophenyl)-N-[4-(diethylamino)phenyl]-5-methyl-1,2-oxazole-4-carboxamide | IC50 | 130.0 [1], 180.0 [2] |
| 1-[2-[(2,2-Dimethyl-3,4-dihydrochromen-6-yl)methyl]-2,7-diazaspiro[3.5]nonan-7-yl]-2-(4-methoxyphenoxy)ethanone | IC50 | 211.0 [1], 213.8 [2] |
| 1-[2-[(2,2-Dimethyl-3,4-dihydrochromen-6-yl)methyl]-2,7-diazaspiro[3.5]nonan-7-yl]-2-(4-methoxyphenoxy)ethanone | Ki | 213.8 [1], 407.38 [2], 408.0 [3] |
| 2-Amino-N-[(1R)-2-(1H-indol-3-yl)-1-[5-[2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]ethyl]-2-methylpropanamide | IC50 | 6.0 [1] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[5-[2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]ethyl]piperidine-4-carboxamide | IC50 | 0.3 [1], 0.6 [2] |
| 2-(4-Methoxyphenyl)-1-[2-[(1R)-5-pyrimidin-2-yl-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | Ki | 6.31 [1], 6.9 [2], 17.38 [3] |
| 5-{4-[(4-Chlorobenzyl)amino]phenyl}-6-ethylpyrimidine-2,4-diamine | IC50 | 310.0 [1], 1380.0 [2], 1400.0 [3] |
| 6-[(Benzyloxy)methyl]-5-(4-{[4-(methylsulfonyl)benzyl]amino}phenyl)pyrimidine-2,4-diamine | IC50 | 0.3 [1], 7.1 [2], 7.2 [3] |
| 6-Benzyloxymethyl-5-[4-(4-chloro-benzylamino)-phenyl]-pyrimidine-2,4-diamine | IC50 | 19.0 [1], 180.0 [2] |
| 3-(2,6-Dichlorophenyl)-N-[4-(diethylamino)phenyl]-5-[2-(1,3-dioxan-2-yl)ethyl]-1,2-oxazole-4-carboxamide | IC50 | 6.0 [1], 14.0 [2], 19.0 [3] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 1.3 [1], 2.0 [2], 4.0 [3] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 10.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Formamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 3.0 [1], 3.4 [2], 8.0 [3] |
| N-[(1R)-1-[5-[(1R)-1-Formamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 8.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-hydroxyacetamide | IC50 | 2.0 [1], 3.0 [2], 8.0 [3] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-hydroxyacetamide | Ki | 0.8 [1] |
| (2S)-N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]morpholine-2-carboxamide | IC50 | 3.0 [1], 3.4 [2], 9.0 [3] |
| (2S)-N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]morpholine-2-carboxamide | Ki | 2.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | IC50 | 1.4 [1], 19.0 [2], 22.0 [3] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | Ki | 12.0 [1] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | IC50 | 3.2 [1], 33.0 [2], 60.0 [3] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | Ki | 46.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 0.6 [1], 2.0 [2], 3.0 [3] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 9.0 [1] |
| Growth hormone releasing hexapeptide | IC50 | 6.08 [1], 6000.0 [2] |
| Growth hormone releasing hexapeptide | Ki | 6.0 [1] |
| Capromorelin | IC50 | 19.95 [1], 3000.0 [2] |
| Capromorelin | Ki | 7.0 [1] |
| 1-[2-[[2-Chloro-4-(triazol-2-yl)phenyl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]-2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)ethanone | IC50 | 4.6 [1] |
| 1-[2-[[2-Chloro-4-(triazol-2-yl)phenyl]methyl]-2,7-diazaspiro[3.5]nonan-7-yl]-2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)ethanone | Ki | 5.5 [1], 7.0 [2] |
| 2-Methylpropyl N-[2-[[4-(diethylamino)phenyl]carbamoyl]-8-methoxy-3,4-dihydro-1H-naphthalen-2-yl]-N-methylcarbamate | IC50 | 16.0 [1], 29.0 [2] |
| Wfwll-NH2 | IC50 | 530.0 [1], 1000.0 [2] |
| 3-(2,6-Dichlorophenyl)-N-[4-(diethylamino)phenyl]-5-[2-(2-oxopiperidin-1-yl)ethyl]-1,2-oxazole-4-carboxamide | IC50 | 8.0 [1], 9.0 [2] |
| 2-(5-Methoxypyridin-2-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | Ki | 12.88 [1], 14.0 [2], 16.98 [3] |
| 2-(5-Methoxypyridin-2-yl)-1-[2-[(1R)-5-(5-methylpyrimidin-2-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | Ki | 9.12 [1], 85.11 [2] |
| 2-(5-Methoxypyridin-2-yl)-1-[2-[(1R)-5-pyrimidin-2-yl-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | Ki | 25.12 [1], 29.51 [2] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-3-carboxamide | IC50 | 122.0 [1], 337.0 [2], 411.0 [3] |
| 5-Bromo-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-3-carboxamide | IC50 | 84.0 [1], 88.0 [2], 222.0 [3] |
| 2-Bromo-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-3-carboxamide | IC50 | 193.0 [1], 250.0 [2], 510.0 [3] |
| 6-Chloro-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-3-carboxamide | IC50 | 130.0 [1], 771.0 [2], 1010.0 [3] |
| 2-Amino-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-3-carboxamide | IC50 | 380.0 [1], 427.0 [2], 671.0 [3] |
| 3-Fluoro-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-2-carboxamide | IC50 | 3.0 [1], 7.0 [2], 8.8 [3] |
| 6-Fluoro-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-2-carboxamide | IC50 | 2.0 [1], 2.1 [2] |
| 3,5-Difluoro-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-2-carboxamide | IC50 | 2.8 [1], 4.0 [2], 4.6 [3] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]-6-methylpyridine-2-carboxamide | IC50 | 3.4 [1], 5.4 [2], 7.5 [3] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]-6-methoxypyridine-2-carboxamide | IC50 | 2.0 [1], 7.8 [2], 9.0 [3] |
| 6-Amino-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-2-carboxamide | IC50 | 6.0 [1], 21.0 [2], 25.0 [3] |
| 3-Hydroxy-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-2-carboxamide | IC50 | 108.0 [1], 165.0 [2], 240.0 [3] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]-1-oxidopyridin-1-ium-2-carboxamide | IC50 | 42.0 [1], 79.0 [2], 112.0 [3] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]-5-pyrrolidin-1-ylpyridine-2-carboxamide | IC50 | 65.0 [1], 1210.0 [2], 2115.0 [3] |
| 3-Benzoyl-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-2-carboxamide | IC50 | 230.0 [1], 240.0 [2], 313.0 [3] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]isoquinoline-1-carboxamide | IC50 | 73.0 [1], 82.0 [2], 150.0 [3] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]isoquinoline-3-carboxamide | IC50 | 100.0 [1], 126.0 [2], 404.0 [3] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | IC50 | 1000.0 [1] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | Ki | 1000.0 [1] |
| 2-Amino-N-[(1R)-1-[5-[(1S)-1-amino-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | IC50 | 1000.0 [1] |
| 2-Amino-N-[(1R)-1-[5-[(1S)-1-amino-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | Ki | 1000.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-3,4-dihydro-2H-pyran-6-carboxamide | IC50 | 3.0 [1], 4.0 [2] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-3,4-dihydro-2H-pyran-6-carboxamide | Ki | 9.0 [1] |
| N-[(1R)-1-[5-[(1S)-1-Formamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 410.0 [1], 1200.0 [2] |
| N-[(1R)-1-[5-[(1S)-1-Formamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 154.0 [1] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 100.0 [1], 190.0 [2] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 62.0 [1] |
| 2-Amino-N-[(1R)-1-[5-[(1S)-1-amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | IC50 | 1000.0 [1] |
| 2-Amino-N-[(1R)-1-[5-[(1S)-1-amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | Ki | 1000.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-3-fluoropyridine-2-carboxamide | IC50 | 2.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-3-fluoropyridine-2-carboxamide | Ki | 4.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-4,6-difluoropyridine-2-carboxamide | IC50 | 4.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-4,6-difluoropyridine-2-carboxamide | Ki | 11.0 [1] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-amino-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | IC50 | 90.0 [1], 130.0 [2] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-amino-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | Ki | 131.0 [1] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | IC50 | 1000.0 [1] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-(1H-indol-3-yl)ethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | Ki | 1000.0 [1] |
| N-[(1R)-1-[5-[(1S)-1-Amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 150.0 [1], 320.0 [2] |
| N-[(1R)-1-[5-[(1S)-1-Amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 62.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 4.0 [1], 7.0 [2] |
| N-[(1R)-1-[5-[(1R)-1-Amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 18.0 [1] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | IC50 | 115.0 [1], 135.0 [2] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-amino-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | Ki | 154.0 [1] |
| N-[(1R)-2-(1H-Indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]pyridine-2-carboxamide | IC50 | 0.7 [1], 4.5 [2], 6.0 [3] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-formamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | IC50 | 43.0 [1], 113.0 [2] |
| 2-Amino-N-[(1R)-1-[5-[(1R)-1-formamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-methylpropanamide | Ki | 59.0 [1] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | IC50 | 70.0 [1], 360.0 [2] |
| N-[(1R)-1-[5-[(1S)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]pyridine-2-carboxamide | Ki | 17.0 [1] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | IC50 | 70.0 [1], 90.0 [2] |
| N-[(1R)-1-[5-[(1R)-1-Acetamido-2-phenylethyl]-4-[(4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-2-(1H-indol-3-yl)ethyl]-2-amino-2-methylpropanamide | Ki | 46.0 [1] |
| (6S,9S,12R)-12-Benzyl-6-[(2S)-butan-2-yl]-9-(hydroxymethyl)-8-methyl-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione | IC50 | 500.0 [1] |
| (6S,9S,12R)-12-Benzyl-6-[(2S)-butan-2-yl]-9-(hydroxymethyl)-8-methyl-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione | Ki | 100.0 [1] |
| Examorelin | IC50 | 15.9 [1], 18.0 [2] |
| CID 121879 | IC50 | 2800.0 [1] |
| CID 121879 | Ki | 63.0 [1] |
| 2-Amino-N-[(1R)-2-(1H-indol-3-yl)-1-[4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl]ethyl]acetamide | IC50 | 32.0 [1] |